Market Overview

EARLIER: Leerink Boosts Intuitive Surgical Price Target 32%

Share:
Related ISRG
Following Intuitive Surgical's Solid Q2, Citi Asks What's Next
Intuitive Surgical Shares Expected To Trade Significantly Higher, Says Canaccord
Option Plays Loom For Facebook, Mobileye, Ultimate Software (Investor's Business Daily)

Leerink boosted the price target for shares of Intuitive Surgical (NASDAQ: ISRG) from $420 to $555.

Analyst Richard Newitter is bullish on “ISRG's gen surgery penetration prospects (particularly Colorectal) in light of positive feedback on the just-released Xi system.”

Newitter's price target bump is on “now higher 2015 estimates and assuming ISRG sustains a premium valuation vs large-cap MedTech given a monopoly position in robotics.”

“Xi has potential to help re-accelerate system sales growth in 2015 and beyond and to drive higher da Vinci penetration in complex cases -- most notably in colorectal surgery,” according to the analyst.

Newitter lays out two points for investors to focus on going forward on Xi:

  • ”Whether Xi and new features in the works (like advanced single-site) are “must-haves” that will inevitably prompt a widespread replacement cycle.”
  • ”The extent to which multi-quadrant surgery and the promise of more advanced single-site capabilities will drive penetration into other gen surgery areas.”

The stock finished down 1.45 percent to $489.84 in Tuesday's trading.

Latest Ratings for ISRG

DateFirmActionFromTo
Jul 2016BarclaysMaintainsOverweight
Jul 2016CitigroupMaintainsBuy
Jun 2016Goldman SachsDowngradesBuyNeutral

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Leerink Richard NewitterAnalyst Color Analyst Ratings

 

Related Articles (ISRG)

View Comments and Join the Discussion!